MDXHEALTH MDXH
ASignal's systematic analysis rates MDXH as Bearish.
Reflects the latest available analysis · analyzed Nov 14, 2026
The case on MDXH
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI indicates oversold condition (23.16), suggesting potential price rebound
- Gross margin remains strong at 62.23%, indicating pricing power or efficient production
- Price near Bollinger Lower Band (0.1252), historically a potential reversal zone
- Negative price momentum (-0.0828) and trading below both SMA20 and SMA50
- Sustained negative operating and net margins (operating margin: -22.12%, net margin: -38.28%)
- Negative free cash flow (-$13.67M) and declining revenue (YoY growth: -17.20%)
- High debt levels ($105.59M total debt) with limited cash ($31.71M) raising financial health concerns
- EV/EBITDA of -4.52x and negative ROA (-10.71%) signal poor earnings and asset efficiency
See the full verdict on MDXH
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes MDXH
Most investors never get a second opinion, let alone several. ASignal runs MDXH past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.